Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis

Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis

US Patent 11725056 · Granted Aug 15, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary f2025
Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary f2025
Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary f2025
Method effective to modulate expression of T-box protein 4 (Tbx4) for reducing p2021
Method effective to modulate expression of T-box protein 4 (Tbx4) for reducing p2021
Method effective to modulate expression of T-box protein 4 (Tbx4) for reducing p2021
Methods for reducing severity of pulmonary fibrosis2021
Methods for reducing severity of pulmonary fibrosis2021
Methods for reducing severity of pulmonary fibrosis2021
Targeting fibroblast invasion for pulmonary fibrosis2020
Targeting fibroblast invasion for pulmonary fibrosis2020
Targeting fibroblast invasion for pulmonary fibrosis2020